XML 39 R28.htm IDEA: XBRL DOCUMENT v3.23.1
Note 11 - Income Taxes (Tables)
12 Months Ended
Dec. 31, 2022
Notes Tables  
Schedule of Income before Income Tax, Domestic and Foreign [Table Text Block]
   

For the Years Ended December 31,

 
   

2022

   

2021

 

Domestic

  $ (293,253

)

  $ (376,136

)

Foreign

    6,342       2,925  

Net loss before income taxes

  $ (286,911

)

  $ (373,211

)

Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]
   

For the Years Ended December 31,

 
   

2022

   

2021

 
Current:                

Federal

  $ -     $ -  

Foreign

    1,268       585  

State and Local

    -       -  

Total Current

    1,268       585  
                 
Deferred                

Federal

    713,000       1,566,000  

Foreign

    -       -  

State and Local

    1,000      

(10,000

)

Adjustment to valuation allowance related to net deferred tax assets

    (714,000

)

    (1,556,000

)

Total Deferred

    -       -  

Provision for income taxes

  $ 1,268     $ 585  
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]
   

For the Years Ended December 31,

 
   

2022

   

2021

 

Tax provision at statutory rate

    21

%

    21

%

State and local taxes

    2

%

    3

%

Gain from forgiveness of Paycheck Protection Program Loans and related interest

    -      

19

%

General business credit

    9

%

    8

%

Expiration of loss carryforwards and credits

    (280

)%

    (467

)%

Other

    (1

)%

    (1

)%

Change in valuation allowance for net deferred tax assets

    249

%

    417

%

      -

%

    -

%

Schedule of Deferred Tax Assets and Liabilities [Table Text Block]
   

For the Years Ended December 31,

 
   

2022

   

2021

 
Deferred tax assets:                

Accrued expenses

  $ 22,000     $ 16,000  

Allowance for doubtful accounts

    1,000       1,000  

Deferred revenue

    5,000       27,000  

Reserve for obsolescence

    20,000       23,000  

Expense associated with non-qualified stock options

    37,000       37,000  
Capitalized Research and Development Expense     90,000       -  

Revenue Sharing Agreement

    160,000       190,000  

General business credit

    823,000       922,000  

NOL carryforward

    3,603,000       4,259,000  
      4,761,000       5,475,000  

Less: valuation allowance

    (4,761,000

)

    (5,475,000

)

Deferred tax asset, net

  $ -     $ -  
Summary of Valuation Allowance [Table Text Block]
   

For the Years Ended December 31,

 
   

2022

   

2021

 

Beginning Balance

  $ 5,475,000     $ 7,031,000  

Change in Allowance

    (714,000

)

    (1,556,000

)

Ending Balance

  $ 4,761,000     $ 5,475,000